2591.HK · INNOGEN-B
Hong Kong · RS rating 4 · As of 2026-10-14
| Price | 3.81 HKD |
|---|---|
| 1-day change | +1.3% |
| RS rating (overall / 1M / 3M / 12M) | 4 / 38 / 3 / 2 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 24 / 5 / 13 |
| Industry group (rank) | Pharma & Biotech (30) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +91.3% |
| Market cap (USD) | $209.5M |